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Abstract
Background: The inheritance pattern in most cases of autism is complex. The risk of autism is increased in siblings
of children with autism and previous studies have indicated that the level of risk can be further identified by the
accumulation of multiple susceptibility single nucleotide polymorphisms (SNPs) allowing for the identification of a
higher-risk subgroup among siblings. As a result of the sex difference in the prevalence of autism, we explored the
potential for identifying sex-specific autism susceptibility SNPs in siblings of children with autism and the ability to
develop a sex-specific risk assessment genetic scoring system.
Methods: SNPs were chosen from genes known to be associated with autism. These markers were evaluated
using an exploratory sample of 480 families from the Autism Genetic Resource Exchange (AGRE) repository. A
reproducibility index (RI) was proposed and calculated in all children with autism and in males and females
separately. Differing genetic scoring models were then constructed to develop a sex-specific genetic score model
designed to identify individuals with a higher risk of autism. The ability of the genetic scores to identify high-risk
children was then evaluated and replicated in an independent sample of 351 affected and 90 unaffected siblings
from families with at least 1 child with autism.
Results: We identified three risk SNPs that had a high RI in males, two SNPs with a high RI in females, and three
SNPs with a high RI in both sexes. Using these results, genetic scoring models for males and females were
developed which demonstrated a significant association with autism (P = 2.2 × 10-6 and 1.9 × 10-5, respectively).
Conclusions: Our results demonstrate that individual susceptibility associated SNPs for autism may have important
differential sex effects. We also show that a sex-specific risk score based on the presence of multiple susceptibility
associated SNPs allow for the identification of subgroups of siblings of children with autism who have a
significantly higher risk of autism.
Keywords: Autism, risk assessment, common variants, genetic score, sex effects
Background
Autistic disorder is the most severe form of a group of
autism spectrum disorders (ASDs) characterized by
impairments in social interaction, deficits in verbal and
non-verbal communication, restricted interests, and repe-
titive behaviors [1]. With a prevalence of 1 in 110 children,
ASDs are among the most common forms of severe devel-
opmental disability [2]. The average recurrence risk of aut-
ism in siblings of affected children is approximately 10%
[3]. This rate is much higher than the prevalence rate for
ASDs in the general population, but lower than would be
expected for a highly penetrant mutation in a mendelian
disorder [4].
The inheritance pattern of autism in most families is
complex and not compatible with simple Mendelian
inheritance [5,6]. There is significant interest in the early
identification of infants at higher risk for autism because
studies have shown that early intervention leads to signifi-
cantly improved long-term outcome for the whole family
[7,8]. Several common variants localized in biological and
positional (that is, under known linkage peaks) candidate
genes have been associated with autism and some have
been replicated in independent studies [9]. Further
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support for these associations comes from genes for
which, in addition to autism-associated common variants,
rare mutations and/or copy number variations (CNVs)
have been shown to contribute to the disease, and/or for
which gene-disrupted mice exhibited autism-like traits.
These genes include CNTNAP2 [10-13], RELN [14-19]
and GABRB3 [20-23].
When taken individually, the risk of autism associated
with variants remains modest, but Carayol et al. [24]
recently showed that the accumulation of multiple risk
alleles markedly increases the risk of autism in siblings of
children who have been diagnosed with autism. They pro-
posed a genetic score (GS) that, compared with studying
polymorphisms individually, improves the identification of
subgroups of individuals at greater risk of autism [24]. In
the case of autism, tools for genetic risk assessment are
highly desirable to complement available behavioral
assessments.
Another important characteristic of autism is the sex
difference with a 4.5:1 male to female ratio [2]. Second,
intellectual disability, a key clinical dimension associated
with outcome, is more frequent in females than males
[25]. Third, the risk of epilepsy is 18 times higher in
females than males [26]. This sex difference may partly be
explained by sex-specific risk alleles or genes with different
expression or activity based on sex [27,28].
In the present study we propose to improve the genetic
risk score model developed by Carayol et al. [24] by add-
ing additional SNPs filtered for their relative importance
using internal validation process and by also developing
separate sex-specific genetic risk scores for males and
females using a first sample of families with children with
autism (exploratory sample). Their ability to better identify
siblings of children with autism who are at high risk of
autism was then evaluated and replicated in an indepen-
dent second sample of autism families (replication
sample).
Methods
The study design involved two independent family sam-
ples. The first sample (the ‘exploratory’ sample) consisted
of 480 families from the Autism Genetic Resource
Exchange (AGRE; http://www.agre.org) repository with at
least 1 sibling diagnosed with a ‘strict’ definition of autism
according to the Autism Diagnostic Interview Revisited
(ADI-R) and no unaffected siblings. A total of 844 affected
siblings including 664 males and 179 females met the diag-
nostic criteria for ‘strict’ autism. Minimizing phenotypic
heterogeneity can lead to an improvement of the study
power [29]. Shao et al. [30] demonstrated that the use of
homogeneous phenotype increases the power of linkage
studies in autism. Linkage signals have been observed in
studies in which the samples were stratified according to
specific phenotypes such as the sex [28,31,32], delayed
onset of phrase speech [30,33,34], and severe obsessive-
compulsive behaviors [35]. Two genome-wide association
studies using overlapping samples of children with autism
identified two different common variants in CNTNAP2, a
gene localized in the 7q34-7q36 region linked to language
disability in autism [36]; one SNP has been associated with
autism through the use of the quantitative trait ‘age at first
word’ [10] and the other using a qualitative strict autism
diagnosis [11]. Similarly, a recent genome-wide association
study (GWAS) [37] reported the largest association with
autism in MACROD2 using the strict autism diagnosis.
Therefore, as in Shao et al. [30], we studied individuals
with a strict autism rather than the heterogeneous broad
autism spectrum disorder phenotype. The second sample
(the ‘replication’ sample) included 187 families consisting
of the 2 parents, at least 1 child with autism and 1 unaf-
fected sibling from a sample collection at the University of
Pennsylvania. This replication sample led to 351 children
with autism (291 males and 60 females) with the same
strict definition of the disease and 90 unaffected children
(39 males and 51 females). Ethnicity was self-reported by
parents as Caucasian, Asian, Hispanic or Latino, Black or
African American, Native Hawaiian or other Pacific Islan-
der, or of mixed ethnicity. Caucasians represented the
major ethnicity, with more than two-thirds of families in
each sample.
Ten autism susceptibility genes were selected for this
study. Four of them (PITX1, EN2, SLC25A12 and
ATP2B2) have been previously demonstrated to have a
predictive ability and were used in a genetic score-based
model [24]. Genes shown to be statistically associated
with autism in at least one study using AGRE collection,
even at the nominal level, and for which additional data
support their implication in autism, were also included.
Six genes fulfilled the statistical association condition,
four of which were replicated in one or more indepen-
dent study: HOXA1 [38,39], GRIK2 [40-42], ITGB3
[43-46] and CNTNAP2 [10,11]; one gene, MARK1, was
found to be significantly overexpressed in brain from
individuals with autism compared to unaffected indivi-
duals [47] and the last gene, JARID2 was chosen since
one SNP, rs7766973, displays the strongest association
with autism (P = 6.8 × 10-7 [48]) among the three GWAS
performed on AGRE family data [37,42,48]. Table 1 lists
the genes selected for the study and the associated SNPs
with their deleterious alleles and corresponding
frequencies.
All parents and children from the exploratory sample
were genotyped for these ten markers. Only SNPs that
were selected for further investigation were genotyped in
the replication sample. Genotyping was performed using
TaqMan allele discrimination assays (Applied Biosystems,
Foster City, CA, USA). Genotyping was performed in 384-
well plates with 5 ng genomic DNA, 0.075 μl of 20 × SNP
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TaqMan Assay mix, 1.5 μl of TaqMan Universal PCR
Master Mix and 1.425 μl of dH2O in each well. PCR was
performed at 95°C for 10 min, followed by 50 cycles at
92°C for 15 s and 60°C for 90 s (9700 Gene Amp PCR Sys-
tem; Applied Biosystems). Plates were then subjected to
endpoint reading (7900 Real-Time PCR System; Applied
Biosystems). The alleles were called automatically using
the SDS software (Applied Biosystems), and a visual
inspection of genotype clusters was performed. Genotyp-
ing quality was assessed by signal intensity plots and miss-
ing genotype frequencies; any sample with poor clustering
and missing fractions ≥5% per SNP were retyped. Parental
genotypes were used to investigate Hardy-Weinberg equi-
librium (HWE) and to check for Mendelian inconsisten-
cies. Families with remaining inconsistencies were
excluded.
The development of the genetic score model and the
definition of the increased risk GS thresholds (that define
the high-risk groups) were based on the exploratory sam-
ple with all affected children whereas, for the replication
study using the second sample, the index cases were
excluded.
A model that is efficient only in the sample in which it
was developed does not have validity. To be valid, the
results need to be reproduced in a separate independent
population. A genetic score model, such as the one pro-
posed in this paper, is generally built on the simple sum of
deleterious alleles observed at each of the chosen genes.
Thus, the reproducibility of the genetic score is condi-
tioned by the reproducibility of the deleterious allele for
each SNPs included in the model. Markers that are more
reproducible carry stronger and more stable information.
The reproducibility of the SNPs was analyzed using the
bootstrap resampling process and a reproducibility index
(RI) was estimated similarly to Ma [49] as follows: (1)
generation of a ‘pseudosample’ consisting of 480 families
by randomly sampling the 480 families of the exploratory
population with replacement; (2) estimation of the genetic
relative risk associated with the deleterious allele of each
SNP as defined in Table 1; (3) repetition 1,000 times of
steps 1 and 2; (4) estimation for each SNP of the RIs indi-
cating the proportion of ‘pseudosamples’ in which the
deleterious allele maintains a risk greater than 1.00 in
males, in females or in both males and females.
A high RI indicates that the effect of a deleterious
allele of a given SNP is maintained across the bootstrap
pseudosamples and that this SNP is a good candidate
for the reproducibility of the genetic score. A stringent
RI = 0.80 in children with autism was set to select best
SNPs. Then, the RI in males and females with autism
was checked separately to discard SNPs that lack of sta-
bility in a particular sex. Since all variants have been
associated with autism using AGRE family data, this
internal validation process prevents from an optimistic
evaluation of their association, that is, an overestimation
of the effect of risk alleles, and a potential deterioration
of this effect in an independent sample. The sex genetic
scores (GS) was then constructed as follows:
GSsex = Wall · RSall + Wsex · RSsex
where sex = (male, female); RSall and RSsex are the risk
scores built as the sum of deleterious alleles from genes
with a high RI in males only (RSmale), in females only
(RSfemale) or in both sexes (RSall); and Wall, Wmale, and
Wfemale are the integer values of the corresponding
genetic relative risks (GRR) associated with the corre-
sponding risk scores (RSall, RSmale and RSfemale, respec-
tively). These weights were calculated following Lin
et al. [50] who showed that a weighted genetic score
Table 1 Risk allele frequency (defined as the allele associated with autism)
Gene SNP Risk allele Exploratory sample Replication sample
Frequency HWEa Frequency HWEa
MARK1 rs12410279 A 0.85 0.26 0.83 1.00
SLC25A12 rs2292813 C 0.90 1.00 NEb NE
ATP2B2 rs2278556 A 0.40 0.68 0.38 0.11
PITX1 rs6872664 C 0.89 1.00 0.85 0.32
GRIK2 rs2235076 G 0.98 1.00 NE NE
HOXA1 rs10951154 T 0.86 0.02 0.86 1.00
CNTNAP2 rs7794745 T 0.40 0.73 0.39 0.04
EN2 rs1861972 A 0.73 0.68 0.76 0.90
ITGB3 rs5918 T 0.87 1.00 0.85 0.85
JARID2 rs7766973 C 0.60 0.22 0.58 0.76
aHardy-Weinberg Equilibrium (HWE) P value estimated with the exact test [65].
bNE, not estimated since not genotyped in the replication sample.
SNP, single nucleotide polymorphism.
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provided more predictive value than an unweighted
genetic score.
Because the exploratory sample did not include unaf-
fected children, all genetic relative risks were estimated as
described in Carayol et al. [24] using the case-pseudocon-
trol approach proposed by Cordell and Clayton [51] and
implemented in the DGCgenetics R package (http://www-
gene.cimr.cam.ac.uk/clayton/software/). Sensitivity and
specificity values of the GSs were estimated in the explora-
tory and the replication samples as in Carayol et al. [24].
Areas under the receiver operating curves (AUCs) were
estimated in the exploratory sample and tested against the
AUC = 0.5 null hypothesis to validate the discriminative
power of the GSs. However, AUCs do not provide an
informative tool of the clinical utility of the genetic score
(here, the high-risk classification of siblings of children
with autism). Cutoff values were chosen to define a high-
risk group in the exploratory sample and the odds ratios
were estimated. These high-risk thresholds (one for male
and one for female) were selected considering a false posi-
tive rate lower than 20% (that is, specificity higher than
80%). External validation of the clinical utility of the high-
risk GS group was then conducted in the replication sam-
ple. Positive predictive values in siblings of children with
autism were estimated from the sensitivity, specificity and
the sibling recurrence risk estimates in males and females.
Since no data were available in the literature, we estimated
the sibling recurrence risk to 0.16 in males and 0.04 in
females assuming an overall 0.10 sibling recurrence risk
[3] and a 4:1 male to female sex ratio [2].
Results
None of the SNPs exhibited a departure from HWE and
allele frequencies were similar between samples (Table 1).
Table 2 lists the RI of each SNP based on the bootstrap
analysis using the exploratory sample. Eight markers
reached the stringent 80% RI threshold. SNPs rs2292813
(SLC25A12) and rs2235076 (GRIK2) were excluded
because of their low reproducibility (RI = 52% and 36%,
respectively). Among the eight remaining SNPs, two dis-
played low RI in males but RI of 100% in females,
rs12410279 (MARK1, RImale = 47%) and rs5918 (ITGB3,
RImale = 65%). Inversely, three SNPs displayed a low RI in
females and RI greater than 95% in males, rs227855
(ATP2B2, RIfemale = 59%), rs6872664 (PITX1, RIfemale =
30%) and rs10951154 (HOXA1, RIfemale = 20%).
The three separate risk scores were then constructed
based on the sum of deleterious alleles in their corre-
sponding SNPs. These included rs7794745, rs1861972 and
rs7766973 for RSall, rs12410279 and rs5918 for RSfemale,
and rs2278556, rs6872664 and rs10951154 for RSmale. The
GRRs associated to one point increase in the RS were esti-
mated to be 1.23 for RSall (P = 2.3 × 10
-5; 95% confidence
interval (CI) 1.12 to 1.36), 1.25 for RSmale (P = 5.8 × 10
-4;
95% CI 1.10 to 1.41) and 2.29 for RSfemale (P = 1.7 × 10
-6;
95% CI 1.57 to 3.34). The overall P value of the three
tested scores were 3.1 × 10-9 with corresponding weights
of 1.00, 1.00 and 2.00 for RSall, RSmale and RSfemale, respec-
tively. The two genetic scores (GSs) were then con-
structed. GSmale ranged between 3 and 12 with a GRR
associated to 1 point increase in the score of 1.23 (P =
2.2 × 10-6; 95% CI 1.13 to 1.34) and GSfemale ranged
between 4 and 14 with a GRR of 1.41 (P = 1.9 × 10-5; 95%
CI 1.21 to 1.65) for a highly significant global test with P =
8.4 × 10-10. Table 3 displays the sensitivity and specificity
values for the GS in males and females. To define the
high-risk group, GS values were selected in males and
females with the aim to minimize the number of false
positive below 20% and to maximize the sensitivity as high
as possible. A genetic score threshold of nine points for
males was associated with a moderate 0.24 sensitivity (95%
CI 0.19 to 0.28) and a 0.86 specificity (95% CI 0.82 to 0.90)
that minimizes the number of false positive test to 0.14
and lead to a 0.23 positive predictive value (PPV). For
Table 2 Reproducibility indexes (RIs) in children with autism, in males and in females
Gene SNP RI in children with autism RI in male children with autism RI in female children with autism
MARK1 rs12410279 0.93 0.468 1.00
SLC25A12 rs2292813 0.52 0.757 0.52
ATP2B2 rs2278556 0.99 0.997 0.59
PITX1 rs6872664 0.97 0.983 0.30
GRIK2 rs2235076 0.36 0.277 0.59
HOXA1 rs10951154 0.93 0.958 0.20
CNTNAP2 rs7794745 1.000 1.000 0.89
EN2 rs1861972 0.97 0.880 0.94
ITGB3 rs5918 0.98 0.646 1.00
JARID2 rs7766973 0.98 0.951 0.88
RIs that reached the 80% threshold are in bold.
SNP, single nucleotide polymorphism.
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females, a genetic score threshold of 12 was associated
with a similar specificity of 0.86 (95% CI 0.80 to 0.92) but
a higher sensitivity of 0.37 (95% CI 0.29 to 0.44) and a
PPV of 0.09. These two GS values were chosen as thresh-
olds to define the group of children with a high risk of aut-
ism. AUCs were estimated to be 0.59 and 0.66 in males
and females, respectively. They are both significantly dif-
ferent from the 0.5 null hypothesis (P = 2 × 10-8 and 1.5 ×
10-7) indicating a predictive ability of the GSs.
In the replication sample (Table 4), sensitivity and speci-
ficity associated with the high-risk group GS threshold
(GSmale = 9) were slightly higher in males (but not signifi-
cantly different as it can be seen from the overlapping 95%
CIs) with a 0.26 (95% CI 0.18 to 0.35) sensitivity and 0.87
(95% CI 0.76 to 0.98) specificity. The PPV reached 0.28 for
a 0.16 sibling recurrence risk. Differences were observed
in females for the sensitivity with an estimated 0.28 (95%
CI 0.12 to 0.44) instead of 0.37 and the specificity with a
0.76 specificity (95% CI 0.64 to 0.89) instead of 0.86 but
the differences were not significant (overlapping confi-
dence intervals). In females, variances for sensitivity and
specificity values were larger in the replication sample
than in the exploratory sample because of the smaller
number of females in the replication sample. As a conse-
quence, the PPV (estimated to 5%) was very small and
close to the 4% sibling recurrence risk.
Extending the analysis to a broader definition of aut-
ism and including or excluding the index cases as was
performed with the replication study did not change the
characteristics of the genetic score or the associated sig-
nificance levels.
Discussion
Our results demonstrate that the sex difference in autism
may have an important influence on the genetic score
characteristics, and therefore, on the risk assessment. Tak-
ing sex and reproducibility of the SNPs into account led to
two GSs with different characteristics that allowed the
identification of a subgroup of siblings of children with
autism with a high risk of autism in males. The genetic
score model with four genes [24] was also tested on this
large sample of families and its association was clearly
lower (P = 7 × 10-4 in males and females as a whole) com-
pared to those of the sex-specific GSs (P = 2.2 × 10-6 and
1.9 × 10-5 for males and females, respectively). The risk for
males with a high GS to develop autism was 28%, almost
three times higher than the reported 10% sibling recur-
rence risk. In females, the 10% recurrence risk seems over-
estimated and we estimate this value to 4% considering a
4.5:1 male to female sex ratio.
The GS model has been developed through the use of
affected children and the pseudocontrol approach
[52,53]. This was confirmed by analyzing unaffected sib-
lings of children with autism. The pseudocontrols
approach has been validated for the estimation of diag-
nostic accuracy using only affected children compared to
full population-based data [54]. We cannot exclude an
Table 3 Genetic score (GS) sensitivities and specificities with their 95% CIs by sex estimated in the exploratory sample
Genetic score threshold Males Females
Sensitivity (95% CI) Specificity (95% CI) Sensitivity (95% CI) Specificity (95% CI)
3 1.00 0.000 - -
4 1.00 (0.99 to 1.00) 0.01 (0.01 to 0.02) 1.00 0.00
5 0.97 (0.94 to 1.00) 0.03 (0.02 to 0.05) 1.00 0.00
6 0.90 (0.85 to 0.94) 0.19 (0.15 to 0.22) 1.00 0.00
7 0.75 (0.70 to 0.80) 0.41 (0.36 to 0.46) 1.00 0.00
8 0.47 (0.43 to 0.52) 0.64 (0.59 to 0.69) 0.99 (0.98 to 1.00) 0.10 (0.00 to 0.19)
9 0.24 (0.19 to 0.28) 0.86 (0.82 to 0.90) 0.90 (0.85 to 0.96) 0.20 (0.15 to 0.25)
10 0.08 (0.06 to 0.11) 0.95 (0.92 to 0.97) 0.78 (0.71 to 0.85) 0.40 (0.31 to 0.49)
11 0.02 (0.01 to 0.04) 0.98 (0.96 to 0.99) 0.61 (0.52 to 0.69) 0.65 (0.57 to 0.74)
12 0.00 1.00 0.37 (0.29 to 0.44) 0.86 (0.80 to 0.92)
13 - - 0.17 (0.11 to 0.23) 0.94 (0.89 to 0.98)
14 - - 0.03 (0.01 to 0.06) 0.99 (0.97 to 1.00)
The two GSs chosen as threshold value to define children with a higher risk of autism in males and in females are shown in bold.
Table 4 Sensitivity and specificity estimates in the
exploratory and replication samples with their
corresponding 95% CIs for the high-risk group
Exploratory sample Replication sample
Males:
Sensitivity 0.24 (0.19 to 0.28) 0.26 (0.18 to 0.35)
Specificity 0.86 (0.82 to 0.90) 0.87 (0.76 to 0.98)
Females:
Sensitivity 0.37 (0.29 to 0.44) 0.28 (0.12 to 0.44)
Specificity 0.86 (0.80 to 0.92) 0.76 (0.64 to 0.89)
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over-representation of deleterious alleles in unaffected
siblings compared to pseudocontrols, which are geneti-
cally the opposite of affected children, nor the effect of
population controls that may lower the risk ratio between
affected and unaffected siblings and consequently affect
the discriminative ability of the GS models. This does not
seem to occur for males since the high-risk class repli-
cates its predictive accuracy but would need further
investigation for females.
Reproducibility of effects is of major interest to enter in
a predictive model since it conditions the reproducibility
of the predictive model outside the study sample, which
is of primary importance to validate such a model.
According to the replication of the performance of the
risk assessment model in males in an independent sample
and the ability to find support for female specific variants
despite the relatively small number of samples, the pro-
posed approach can be used for developing stable and
reproducible models. SLC25A12 associated and repli-
cated in different studies [55-58] did not reach the repro-
ducibility thresholds, whereas JARID2 that reached a
suggestive significant threshold in a unique GWAS [48]
seems of more interest. Some markers were reproducible
(high RI) in a specific sex only but did not show any sta-
tistically significant interaction with sex nor were
reported as being sex specific in the literature. The SNP
rs7794745 located within CNTNAP2 has a high RI in
both sexes whereas a previous association with autism
has been reported preferentially in males [10,11]. Due to
the low number of females analyzed, these studies lack
power to observe any association in females [11].
Another SNP, rs5918 located within ITGB3, has been
shown to be associated with autism in both sexes but
with different risk effect [46], which could explain the dif-
ference of reproducibility observed in males and females.
The stability is not necessarily linked to the sex specificity
of the SNP or to the strength of previous association
results. This may be explained in part by a study of
Jakobsdotir et al. [59] which showed that a highly signifi-
cant association of genes with a disease does not guaran-
tee an effective discrimination between cases and
controls.
Several limits of the study may be identified. The moder-
ate number of females with autism in the replication sam-
ple as a consequence of the significant sex ratio in autism
led to a lack of power for the replication of the high-risk
group characteristics. Sibling recurrence risk of males and
females were not estimated or reported from real data but
calculated assuming a sibling recurrence risk of 10% [3]
and the widely observed 4.5:1 male to female sex ratio.
Reported PPVs are intuitive estimates that quantify the
increase in the risk for an individual (a sibling of a child
with autism) who has a genetic score that falls in the high-
risk class. Accurate PPVs could be estimated by using
observed and reported data. The selection of the genes
and the SNPs included in the genetic scores could be dis-
cussed. The methodology used to select the common var-
iants and the internal validation approach performed in
this study strongly support the implication of these SNPs
in autism as well as their discriminative ability. The addi-
tion of other SNPs from the same genetic region would
have led to a much more complicated model because of
the linkage disequilibrium (LD) between these SNPs as
well as the haplotypes resulting from the different combi-
nation of alleles. Finally, other approaches may be used to
select genes to enter in a genetic score. Genes may be
selected using statistically significant results from GWAS
[60,61] or a complementary approach as in convergent
functional genomics (CFG) autism [62,63], when none or
few association results reach significance as it is frequently
the case in complex disease and particularly in autism.
The recent paper of Lu and Cantor [64] together with
the present results highlights the importance of the sex in
genetic study of autism. They showed that using sex as a
risk factor in GWAS of multiplex autism families
increased the power of the study and identified one new
gene implicated in calcium channel defect. Stone et al.
[28] also suggested that sex is an important factor in the
genetics of autism and could be used to decrease heteroge-
neity in genetic study.
Conclusions
The results of this study confirm previous results [24] that
predictive models are of major interest in autism and may
help to identify siblings of children with autism at high
risk of disease. The choice of genes to enter in the model
must be made with caution since association and replica-
tion of a particular SNP in different studies are not suffi-
cient justification to enter a SNP in a genetic score and
sex is an important factor that needs to be included in aut-
ism risk evaluation.
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